Paradigm BioCapital Advisors LP 13D and 13G filings for Cogent Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:34 pm Sale | 2025-09-30 | 13G | Cogent Biosciences, Inc. COGT | Paradigm BioCapital Advisors LP | 3,156,398 2.300% | -7,196,051 (-69.51%) | Filing |
| 2025-08-14 4:31 pm Purchase | 2025-06-30 | 13G | Cogent Biosciences, Inc. COGT | Paradigm BioCapital Advisors LP | 10,352,449 9.100% | 1,388,794 (+15.49%) | Filing |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | Cogent Biosciences, Inc. COGT | Paradigm BioCapital Advisors LP | 8,963,655 7.900% | 3,403,731 (+61.22%) | Filing |
| 2025-02-12 4:35 pm Purchase | 2025-02-05 | 13G | Cogent Biosciences, Inc. COGT | Paradigm BioCapital Advisors LP | 5,559,924 5.000% | 5,559,924 (New Position) | Filing |